Article Details
Retrieved on: 2025-02-09 14:08:18
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Interim results from a Phase 2/3 study of Novavax's updated COVID-19 vaccine, NVX-CoV2601, show significant improvements in immune response, ...
Article found on: www.contagionlive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here